Orexa
Manufacturing · Netherlands · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Berghemseweg 8, Herpen, North Brabant, 5...Website
www.orexa.euRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Orexa
Orexa is a clinical-stage pharmaceutical company that develops therapeutics to increase food intake. Its lead compound is a proprietary oral formulation for human use, based on a well known anesthetic. The company has started its first phase 2 study, in the prevention of Post-Operative Ileus, with the first patient dosed in January 2016, and its second phase 2 study, in Anorexia Nervosa, with expected inclusion of the first patient in Q2-2016. Further, it is in preparation of a third phase 2 study in Cachexia. In all these three indications increased food intake could lead to an improved patient health, a shorter hospital stay and significant cost savings. Orexa was founded in 2016 and is headquartered in Herpen (Oss Region, Noord Brabant), The Netherlands.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orexa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Orexa launches new products
Check out if Orexa is spiking on competitors!
Orexa, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Orexa has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Orexa recently announced quarterly report
Click to see if Orexa had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Orexa has new funding data
Congratulate Masked Content for being promoted to Masked Content at Orexa
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Orexa
Find 3 more new buyers
Company Profile Activity
Activity Insights
Orexa is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Orexa is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Orexa.
Orexa financials insights
Gather financial insights about Orexa, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Unspecified
$939K
Orexa Tech Stack
A closer look at the technologies used by Orexa
See more technologies
Orexa News & Media
Orexa Announces First Patient Dosed in Phase 2 Trial in Post-Operative Patients
HERPEN, The Netherlands, Feb. 8, 2024 /PRNewswire/ -- Orexa B.V., a Dutch life sciences company that is developing a new medicine that increases food intake and supports health in patients, announces that the first patient has been dosed in a Phase 2 clinical trial in the prevention of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orexa
Sign Up For FreeTo access detailed company insights
Orexa is a clinical-stage pharmaceutical company that develops therapeutics to increase food intake. Its lead compound is a proprietary oral formulation for human use, based on a well known anesthetic. The company has started its first phase 2 study, in the prevention of Post-Operative Ileus, with the first patient dosed in January 2016, and its se... Read More
